中文产业新闻评分60Chinese source
ArriVent伏美替尼FURVENT全球三期临床失败，股价单日大跌52%
ArriVent股价腰斩：伏美替尼全球三期临床失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
ArriVent股价腰斩：伏美替尼全球三期临床失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.